Trend in approval of targeted biologics in the last two decades
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
1. autor: | Siddika, Khadiza |
---|---|
Kolejni autorzy: | Ahmed, Syeda Maliha |
Format: | Praca dyplomowa |
Język: | English |
Wydane: |
Brac University
2024
|
Hasła przedmiotowe: | |
Dostęp online: | http://hdl.handle.net/10361/24296 |
Podobne zapisy
-
Targeted therapeutic options in the treatment of Breast Cancer
od: Alam, Kazi Tasnuva
Wydane: (2022) -
Study on anticancer drugs approved by the FDA from 2014 to 2023
od: Rattry, Faria Rahman
Wydane: (2024) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
od: Tania, Umme
Wydane: (2023) -
RIPK pathway, as a potential target, for cancer treatment - a review
od: Jahan, Nusrat
Wydane: (2024) -
Molecular biology : genes to proteins /
od: Tropp, Burton E.
Wydane: (2008)